About Us – Azento Health®

Who We Are

Azento Health AG is a Swiss healthcare company dedicated to advancing innovation at the intersection of obesity, weight management, and the gut microbiome.

Our purpose is clear:

“To enhance overall health and combat obesity through optimized gut health.”

Our mission:

“To empower patients on a weight loss journey with microbiome-based products for everyday health, support, and happiness.”

From our headquarters in Zug, Switzerland, and innovation hub in Copenhagen, Denmark, we bring together purpose, customer focus, European quality, and global scientific expertise to create premium products for modern lifestyles. 

Our Story

Obesity is one of the defining health challenges of our time. GLP-1 medicines are reshaping the treatment landscape, offering new possibilities for people beginning their weight-loss journey. But every journey involves more than medicine – it includes changes in daily routines, nutrition, mindset, and lifestyle.

We founded Azento Health with the conviction that the gut microbiome is a key part of this journey. Trillions of microorganisms in the gut form a living ecosystem that influences digestion, nutrient balance, and metabolic resilience. As people change their diets and routines, this ecosystem shifts – and supporting it may be vital for long-term health and happiness.

Our founding team brings many years of leadership experience in pharma, nutrition, and life sciences:

We are also proud to collaborate with Professor Arne Astrup, MD, DMSc, a world-leading researcher in nutrition and obesity and co-discoverer of GLP-1’s role as a satiety hormone.

Together with other experts and professors in the field of obesity, weight loss, gut microbiome and microbiology, we work every days toward our purpose and mission.

Mads Stoustrup

CEO & Co-Founder

Commercial leader with more than 20 years at Novo Nordisk, where he worked extensively on GLP-1 therapies and obesity care.

Dr. Peter Kaufmann

COO & CSO & Co-Founder

Scientist and business leader, PhD from ETH Zurich, with CEO experience in pharma and nutrition.

Remy Kindle

Sales Director

Healthcare specialist in obesity, diabetes, and cardiovascular care.

Jesper N. Gantzel

Chairman & Co-Founder

Entrepreneur with multiple ventures in probiotics and microbiome businesses.

Scientific advisors to Azento Health

Professor Arne Astrup

MD, DMSc

“I am excited to be part of Azento Health, as their approach for supporting GLP-1 patients is unique.”

Professor Stephen Gough

MD, FRCP

“The azh-biotics scientific platform brings an evidence-driven microbiome approach to supporting people on modern Anti-Obesity-Medications along their treatment journeys.”

Professor Arne Astrup

MD, DMSc

World-leading researcher in nutrition and obesity and co-discoverer of GLP-1’s role as a satiety hormone.

Professor Stephen Gough

MD, FRCP

World-leading clinician and pharmaceutical leader in diabetes, obesity and GLP-1–based therapies, with senior leadership experience from Oxford and Novo Nordisk.

At Azento Health, we are supported by leading scientific and clinical advisors who bring deep expertise across obesity, nutrition, GLP-1 therapy, microbiome science and metabolic health.

Our advisors include Professor Arne Astrup, MD, DMSc, a world-leading researcher in nutrition and obesity and co-discoverer of GLP-1’s role as a satiety hormone, and Professor Stephen Gough, former Global Chief Medical Officer at Novo Nordisk and an internationally recognised leader in diabetes, obesity and GLP-1-based treatment.

Together with a broader network of experts in obesity care, weight management, gut microbiology and clinical development, we are building science-led companion solutions for the full modern weight-loss journey.

Our mission is clear: to support better health, better wellbeing and long-term Health & Happiness.

Our Belief

Every health journey is unique. For those embarking on weight loss with GLP-1 /AOM, the path is rarely straightforward – it brings physical changes, lifestyle adjustments, and moments of challenge that test both body and mind.

At Azento Health, we understand these journeys are about more than numbers on a scale. They are about the daily choices, the resilience to keep going, and the confidence to believe transformation is possible.

We believe in walking alongside people – not with promises of shortcuts, but with the purpose of creating products that bring more health and happiness into everyday life. Our role is to combine science, quality, and human care in ways that make the journey not only possible, but sustainable and rewarding.

The Science

Science is our foundation.

The gut microbiome is one of the fastest-growing areas of global health research. Studies have shown links between microbial ecosystems and:

  • Digestion and nutrient absorption
  • Immune regulation and inflammatory balance
  • Metabolic resilience during dietary change
  • Overall wellbeing and lifestyle adaptation

At Azento Health, we integrate advanced microbiome science with modern technology:

  • CRYO-protected strains that remain stable and viable.
  • Stability-tested CFU counts at expiry, not only at production.
  • Plant-based HPMC capsules for consistency and usability.

We also collaborate with European obesity clinics and invest in clinical studies, real-world evidence studies and generating insights into how products are experienced by people in everyday life.

Looking Ahead

Our vision is to build a portfolio of premium products inspired by microbiome research – tailored to the evolving needs of people on modern health journeys.

The gut microbiome is a vast, largely untapped frontier. Forte80 is only the beginning. At Azento Health, we are building a portfolio of products designed to accompany people throughout their entire GLP-1 journey – before, during, and after treatment.

Before

When someone begins a weight-loss journey, preparing the body and mind is key. Future opportunities include:

  • Foundational microbiome support to help individuals prepare and adapt to dietary and lifestyle changes.
  • Vitamins and micronutrients tailored for those reducing calorie intake, ensuring balanced daily nutrition.
  • Glucose modulation supplements to support stable energy levels as eating patterns shift.

During

The active phase of GLP-1 therapy brings both progress and challenges. Here, we see opportunities to innovate:

  • Targeted strain formulations for different stages of the journey, reflecting evolving dietary patterns and metabolic needs.
  • Muscle mass support concepts, helping consumers preserve strength and vitality as they lose weight.
  • Synergies with nutrition and lifestyle programs, integrating products with coaching, digital tools, or meal planning.
  • Next-generation delivery systems – capsules, powders, or novel formats –  designed for consistency, convenience, and trust.

After

Sustaining results is just as important as achieving them. In the post-GLP-1 phase, future products may include:

  • Maintenance formulations that help people stabilize their microbiome and weight results after rapid dietary change.
  • Personalized supplementation based on diagnostics and microbiome profiling, tailoring support to the individual.
  • Long-term products that combine probiotics with vitamins, minerals, and functional ingredients to maintain balance and longevity.

Beyond

Our ambition goes beyond individual products. We aim to:

  • Collaborate with leading researchers and clinics to explore how microbiome science can improve real-world satisfaction and adherence.
  • Build a trusted ecosystem of products that supports not just weight management, but everyday health and happiness.

At Azento Health, we see the gut microbiome as a key frontier in modern health. By innovating across the consumer journey – before, during, and after GLP-1 treatment – we are creating a new standard at the intersection of science, lifestyle, and wellbeing.

By combining Swiss quality, microbiome innovation, and patient-focused design, Azento Health aims to become a leader in this category.

Our Commitment

At Azento Health, our work is guided by principles that go beyond products, they reflect who we are and why we exist.

  • To science: we ground everything in evidence, collaborate with global experts, and apply the highest standards in developing, production and testing.
  • To quality: every product is designed in Switzerland, manufactured in Europe, and verified with full traceability from strain to capsule.
  • To people: we recognize that every health journey is personal, filled with challenges and milestones that science alone cannot capture.
  • To values: transparency, trust, and care shape every decision we make, because integrity is as important as innovation.

Above all, we are guided by our North Star:

Health and Happiness.

Because behind every capsule, every formulation, every innovation and every study stands a person striving for transformation. Their stories remind us that science is not only about data – it is about improving lives. It is about health and happiness. And it is these journeys that inspire us to keep moving forward.